bariatric surgery that helps When people lose weight, it may also reduce the risk of obesity-related cancers.
that according to research Presented at Gastroenterology Week on May 7a conference of experts in gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Why? The study, which has not yet been published in a peer-reviewed journal, found that significant weight loss may have a protective effect against obesity-related cancers.
Researchers compared the records of more than 55,700 obese patients who had bariatric surgery with a similar number of similar patients who did not.
After 10 years, the group that underwent bariatric surgery had a lower incidence of obesity-related cancers, with significantly fewer breast, liver, colon and ovarian cancers.
Overall, 2,206 patients (4%) who underwent bariatric surgery developed obesity-related cancers compared to 4,960 (8.9%) who developed such cancers without surgery. was.
Yes, but: This is an observational study and cannot identify direct cause and effect.
The researchers controlled for factors such as smoking history and alcohol use, but other factors, such as whether patients had insurance, may have influenced who developed cancer and who did not. there is.
The study could not distinguish when patients received their cancer diagnosis or how much either group lost weight.
Next steps: Future studies could explore whether other obesity treatments, such as lifestyle changes and anti-obesity drugs, have cancer-preventing effects.
By numbers: More than 684,000 obesity-related cancers occur in the United States each year. According to the Centers for Disease Control and Prevention210,000 for men and 470,000 for women.
In women, postmenopausal breast cancer is the most common obesity-related cancer.
In men, colorectal cancer is the most common.
Here we explore the ideas and innovators shaping healthcare.
hundreds of pounds of pasta stranded in the woods New Jersey. Local leaders say it’s “Mission Impossible” to find out who did it.
Share your thoughts, news, tips and feedback with Ben Leonard. [email protected]Ruth Leader [email protected]Carmen Pawn [email protected] or Erin Shoemaker [email protected].
Send tips securely Via SecureDrop, Signal, Telegram, or WhatsApp.
Today is pulse check podcast, Ruth interviews Carmen to help former NIH Director Francis Collins fund African Genomics Center to advance global pandemic preparedness, vaccine development, and control of disease-carrying insects and animals To do.
psychedelic therapy Mental health conditions such as PTSD and depression are attractive to patients who have failed conventional treatments.
However, these patients pay for their treatment out-of-pocket because insurance does not cover it.
That could change, thanks to the American Medical Association’s approval of a medical code for psychedelic therapy and a pathway to reimbursement.
what’s the big deal? In the last few years, ketamine clinics have sprung up to treat everything from anxiety to depression.
The FDA plans to approve a psychotherapy using MDMA, better known as ecstasy, to treat post-traumatic stress disorder in early 2024.
Other psychedelic drugs are in the works.
how did we get here Two psychedelic pharmaceutical companies, MAPS Public Benefit Corporation and Compass Pathways, have applied for the code.
MAPS has led clinical trials of MDMA-assisted psychotherapy for post-traumatic stress disorder.
The company is also researching the medical uses of marijuana and ibogaine, African tree root shrubs that have been shown to be effective in treating addiction.
Meanwhile, Compass Pathways is developing a proprietary form of psilocybin, also known as magic mushrooms, for depression, anorexia, and post-traumatic stress disorder.
what’s next? This code will go into effect on January 1, 2024. These appear to cover psychedelic monitoring services such as therapy, but more details are expected in July.
Patients who used Telemedicine to obtain prescriptions for drugs regulated by the Drug Enforcement Administration will continue to be available for now after the Covid public health emergency ends on May 11.
The DEA’s announcement Wednesday reverses what the DEA said it would do in February when it proposed new rules to roll back pandemic telemedicine rules.
Important reasons: The DEA is probably the government agency most skeptical of telemedicine. Investigating her overprescription of ADHD medication during the pandemic, issued show cause I placed an order with Truepill in December, claiming that a retail pharmacy filled out a prescription for ADHD without a valid medical reason.
But the DEA proposed in February that patients on certain drugs should see a doctor before getting a prescription, and others should go to a doctor’s office to get a refill. was attacked with skeptical comments about
“The Drug Enforcement Administration has received a record 38,000 comments on the proposed telemedicine rule. Milgram said in a statement.
What’s next: The agency said it was still working on the new rules, but did not provide a timeline.
